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Abstract
Objective: To review the state of the art of the scientific literature on binge 
eating disorder in Latin America. Method: A literature search of studies 
conducted in Latin American countries using the term “binge eating” 
was performed in the following electronic databases: PubMed, LILACS, 
SciELO, and PsycINFO. Selected articles described studies developed with 
Latin American samples that met partial or complete DSM-IV diagnostic 
criteria for binge eating disorder. Results: 8,123 articles were screened and 
30 studies met the inclusion criteria (18 cross-sectional studies, 5 clinical 
trials, 4 case reports, 2 validity studies, and 1 cohort study). Most of the 
studies were conducted in Brazil (27), one in Argentina, one in Colombia, 
and one in Venezuela. The prevalence of binge eating disorder among obese 
people attending weight loss programs ranged between 16% and 51.6%. The 
comparison between obese people with and without binge eating disorder 
showed a tendency of higher weight, longer history of weight fluctuation, more 
concern about shape and weight, and association with psychiatric comorbidity 
in those with binge eating disorder. Conclusion: Binge eating disorder is a 
detectable phenomenon in Latin America with clinical features similar to 
those found in the international literature. This review provides support for 
the consideration of binge eating disorder as a distinct eating disorder in the 
International Classification of Diseases – 11th edition. 
Descriptors: Binge eating disorder; International Classification of Diseases; 
Diagnostic and Statistical Manual of Mental Disorders; Diagnosis; 
Classification
Resumo
Objetivo: Revisar o estado de arte da literatura latino-americana sobre o 
transtorno da compulsão alimentar periódica. Método: Foi feita uma busca 
sobre estudos realizados em países latino-americanos usando-se o termo 
“binge eating”, nas seguintes bases eletrônicas: PubMed, LILACS, SciELO e 
PsycINFO. O critério de inclusão foi selecionar estudos desenvolvidos com 
amostras latino-americanas que preencheram critérios parciais ou completos 
do transtorno da compulsão alimentar periódica pelo Manual Diagnóstico e 
Estatístico de Transtornos Mentais-4ª Edição. Resultados: Foram rastreados 
8.123 artigos e 30 preencheram o critério de inclusão (18 estudos de corte 
transversal, cinco ensaios clínicos, quatro relatos de casos, dois estudos 
de validade, um estudo de coorte). A maioria dos estudos foi conduzida 
no Brasil (27), um na Argentina, um na Colômbia e um na Venezuela. A 
prevalência de transtorno da compulsão alimentar periódica em obesos em 
programas para perda de peso esteve entre 16% e 51,6%. A comparação 
entre obesos com e sem transtorno da compulsão alimentar periódica 
mostrou uma maior tendência para peso mais alto, oscilação ponderal, 
preocupação com peso e forma corporal e associação com comorbidades 
psiquiátricas naqueles com transtorno da compulsão alimentar periódica. 
Conclusão: O transtorno da compulsão alimentar periódica mostra-se 
um fenômeno verificável na América Latina com características clínicas 
semelhantes às encontradas na literatura internacional. Esta revisão fornece 
subsídios para que o transtorno da compulsão alimentar periódica seja 
considerado uma categoria distinta de transtorno alimentar na Classificação 
Internacional de Doenças-11ª Edição.
Descritores: Transtorno da compulsão alimentar; Classificação 
Internacional de Doenças; Manual Diagnóstico e Estatístico de 
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Introduction
Two diagnostic classification systems guide the field of mental 
disorders. The first of them, the International Classification of 
Diseases, currently in its 10th edition (CID-10), is officially used 
in all countries.1 The other system is the Diagnostic and Statistical 
Manual of Mental Disorders, in its 4th revised edition (DSM-IV-
TR),2 organized by the American Psychiatric Association, which 
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is used in the United States and widely cited in international 
research.2 These two classification systems are currently under review 
for the publication of their new editions. The systems have two main 
diagnostic categories of eating disorders (ED) in common: anorexia 
nervosa (AN) and bulimia nervosa (BN), among other categories 
of ED that are not diagnostic entities in themselves but include 
partial features of AN and BN or consist of unspecific syndromes 
(see CID-10/WHO,19921 and DSM-IV-TR/APA, 20002).
The occurrence of binge eating episodes (BEE) in obese patients 
was first observed and described by Stunkard, in 1959.3 In 1977, 
Wermuth et al. proposed diagnostic criteria for the binge eating 
syndrome, describing the presence of overeating followed or not by 
induced vomiting.4 The DSM-III5 adopted these criteria in 1980 
and named the disorder “bulimia”. The DSM-III-R6 changed the 
name of this diagnostic category to “bulimia nervosa” in 1987, as 
well as changed the diagnostic criteria by requiring the presence 
of inappropriate compensatory methods of weight control (purging 
methods like induced vomiting, abuse of laxatives, enemas and/
or diuretics, or engaging in excessive physical activity), thus 
restricting the coverage of this category and making it potentially 
more homogeneous.
In the beginning of the 1990s, Spitzer et al. described 
individuals in treatment for weight loss presenting BEE not 
associated with compensatory mechanisms and with different 
features from BN.7 In that multicenter study, the same clinical 
picture occurred in 30.1% of a sample of 1,984 subjects. 
Based on these findings, the authors proposed the inclusion of 
diagnostic criteria for binge eating disorder (BED) in appendix 
B of the DSM-IV as a new diagnostic category requiring further 
investigation. The criteria included: (1) presence of recurrent 
BEE characterized by overeating associated with feelings of loss of 
control; (2) presence of at least three indicators of loss of control 
(eating faster than usual, eating until feeling full, overeating 
without being hungry, eating alone due to embarrassment of 
overeating, and feeling embarrassed, sad or guilty after the 
episode); (3) feelings of distress related to BEE; (4) frequency and 
average duration of BEE of two days per week for six months; 
and (5) no association with the regular use of inappropriate 
compensatory mechanisms to control weight (e.g., purging) or 
with AN and BN. Currently, patients presenting symptoms 
similar to those of BED are classified in the category of “eating 
disorder not otherwise specified” (EDNOS) according to the 
DSM-IV-TR,2 which encompasses many conditions including 
partial presentations of AN and BN, but also presentations 
characterized mainly by recurrent BEE without the regular use 
of compensatory mechanisms.
Since the introduction of criteria for research on BED in 
the DSM-IV (1994),8 this diagnostic category has been widely 
investigated. Literature reviews suggest that BED has similarities 
with other ED that allow the distinction between affected and 
healthy individuals, but also highlight its differences in relation 
to other ED, strengthening its specificity as a distinct condition.9,10 
Although a number of questions on the diagnosis of BED are still 
under discussion, there is enough support to consider its inclusion 
as a new diagnostic category in the DSM-V.9-12
In the ICD-10, however, no reference is made to any diagnostic 
category close to the one currently included in the DSM-IV. 
Patients with overeating associated to loss of control that do 
not resort to compensatory methods may be classified in three of 
the current ED categories in the ICD-10: “ED, unspecified”, 
“atypical BN”, and “overeating associated with other psychological 
disturbances”. These are wide categories encompassing several 
conditions, especially the first one {an useful residual category to 
classify any condition that cannot be assigned to another category). 
In the ICD-10, the category “atypical BN” covers partial 
presentations of BN (those in which one or more BN criteria are 
not fulfilled), such that BEE (as those in BED) could be present 
but not necessarily in association with compensatory mechanisms. 
There is also mention to regular or excessive weight in atypical 
BN, an aspect that is also observed in BED. The third category 
above is intended to diagnose conditions in which overeating may 
lead to obesity and which result from distressing events (mourning, 
accidents, surgeries, etc.). Although no specific mention is made 
to BEE observed in BED in this category, these episodes involve 
overeating and potential weight gain, as well as emotionally 
distressing events. The distribution of individuals with similar 
behavioral manifestations in different categories of the ICD may 
hamper the study of their clinical features, etiological factors, and 
therapeutic strategies. It is important, therefore, that the revision 
of the ICD take into consideration studies on BED so as to enable 
the analysis of the validity and clinical utility of this disorder as 
a new diagnostic category, or, at least, to favor the classification 
of BED patients in a single category of ED.
Despite the significant contribution of the vast literature 
produced mainly in North America and Europe concerning this 
novel potential diagnostic category, little has been discussed about 
BED (or conditions alike) in Latin American populations, since 
the major reviews in this field tend to include few publications in 
Spanish and Portuguese.9,10 This circumstance has raised the interest 
of Latin American clinicians and researchers in investigating the 
extent to which BED can be considered a global syndrome, as well 
as how far it has been investigated and identified as distinct from 
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Results
The searches yielded 8,122 articles published in English, Spanish 
or Portuguese. One more article was selected from the reference lists of 
16 systematic reviews identified in the searches, adding up to a total of 
8,123 articles. The article selection flowchart is described in Figure 1.
Together, the selected studies included a total of 7,514 patients, 
of which 1,025 were diagnosed with BED. The articles included 
in this review were published between 1995 and 2010 and their 
characteristics are outlined in Tables 1-4. Most studies were 
performed in Brazil (n = 27), and Argentina,13 Venezuela,14 and 
Colombia15 contributed with only one article each. The articles were 
classified in the categories “epidemiology” (11 studies summarized 
in Table 1), “clinical characteristics” (9 articles summarized in 
Table 2), “comorbidity” (11 articles detailed in Table 3), and 
“intervention and prognosis” (10 studies in Table 4). Information 
from a same study may be described in more than one table. 
Excluded articles and reasons for exclusion are presented in Table 
5 (available at www.scielo.br/rbp).
The number of participants in each study ranged from 1 
(case report) to 1,971. Clinical samples were enrolled in most 
investigations (n = 28) and only two studies included specific 
samples (students). The age range of participants (not only with 
BED) was 11-65 years (n = 26 articles), and age means ranged 
between 14.1 and 52.9 years (n = 13). In respect to gender, 
16 studies included men and women and 10 enrolled women 
only, excluding the case reports studies (n = 4). The mean BMI 
of participants was in the obesity range, between 30.1 and 
52.2kg/m2 (n = 10). Fourteen studies included only obese subjects.
The prevalence of BED was informed in 11 studies. Nine of 
these investigations, which included clinical samples of obese 
patients13,15-22 seeking treatment, described prevalence rates between 
16% and 51.6%. Only 2 investigations assessed the frequency of 
BED in student samples.14,23 There were no studies concerning the 
prevalence of BED in the general population (Table 1).
Seven studies examined the clinical features of participants with 
BED symptoms. Women with BED had higher weight, more weight 
fluctuations, and were more concerned about body weight and shape 
as compared to women without BED.17,24 The study by Fontenelle and 
colleagues, the only one to use both classificatory systems (DSM-IV 
and ICD-10), described a subgroup of patients with BED symptoms 
(DSM-IV), also classified as atypical BN according to the ICD-10, in 
which the severity of BE assessed with the Binge Eating Scale (BES) 
was higher compared to obese participants without BED (30.05 vs. 
18.32; p < 0.000) (Table 2).25
BED patients had more comorbid psychiatric symptoms or 
diagnoses, especially mood17,22,25,26 and anxiety26,27 disorders. Women 
other ED, obesity, and normality. This review examines studies 
conducted in Latin American countries involving ED patients 
fulfilling the criteria for BED according to the DSM-IV or with 
presentations resembling BED (subthreshold samples) in order to 
broaden the cross-cultural knowledge on BED and contribute for 
the discussion regarding its inclusion as a specific diagnostic category 
in classification systems.
Method
In this comprehensive literature review, we included Latin 
American articles published in indexed journals that used the 
DSM-IV diagnostic criteria for the investigation of BED and its 
subthreshold form. Databases searched included PubMed (1950 
to December 7, 2010), LILACS (1995 to December 7, 2010), 
SciELO (1998 to December 7, 2010), and PsycINFO (1965-
2010). The search term used was “binge-eating” and studies in 
English, Spanish, and Portuguese were selected. Book chapters, 
theses, conference annals, and theoretical articles were not included 
in the review. Systematic reviews by Latin American authors were 
used to complement the screening for Latin American bibliographic 
references (cited in these publications); however, the reference lists 
of selected articles were not checked. The following criteria were 
defined for the inclusion of research articles: (1) studies conducted 
in Latin American countries (involving clinical and general 
population samples comprising mainly Latin American subjects); 
and (2) studies including at least one sample subgroup that fulfilled 
partial or complete DSM-IV2 criteria for the diagnosis of BED 
with no constraints related to gender, age, education, or body 
mass index (BMI). We excluded, however, studies whose findings 
referred to patients with BEE alone and where there were no other 
aspects associated with these episodes that were suggestive of BED 
and allowed its differentiation from others bulimic type diseases or 
other EDNOS, and also studies involving ED patients in which 
results for BED groups were not presented separately.
Two reviewers (M.A.P. and G.H.K.) independently examined the 
titles and abstracts of the references found and selected articles to be 
fully reviewed for subsequent decision concerning their adequacy to 
the purposes of this review. When there were doubts related to the 
fulfillment of the inclusion criteria, the second reviewer was asked 
to examine the articles in question and a third reviewer (A.M.C.) 
was consulted in the case of disagreement, until consensus was 
reached. The three reviewers are clinicians and researchers in the 
field of ED. The selected articles were classified according to the type 
of information provided in the following classes: (1) epidemiology; 
(2) clinical characteristics and diagnostic investigation; (3) 
comorbidity; and (4) intervention and prognosis.
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with BED had higher scores than women without BED in several 
psychopathological domains assessed with the Symptom Checklist 
– 90 (SCL-90)22,25 and lower scores compared to a group with 
symptoms indicative of partial BN.25 BED was associated with 
type 2 diabetes mellitus in two studies28,29 (Table 3).
Although eight studies dealt with pharmacological or 
psychotherapeutic interventions for BED,27,30-36 only two performed 
randomized controlled clinical trials34,36 (Table 4).
Discussion
The findings of this review contribute to the current discussion 
in the literature regarding the status of BED as a distinct pathology 
in relation to other ED. The prevalence of BED in obese Latin 
American populations in treatment for weight loss ranged between 
16% and 51.6%, and between 0.66% and 1.8% among youth. 
Evidence17,24 shows that BED patients have higher weight, greater 
weight oscillation, and higher concerns about body weight and 
shape compared to those without BED. An important association 
of BED with other psychiatric conditions was found, especially 
mood17,22,25,26 and anxiety26,27 disorders. Obese individuals with 
BED were responsive to pharmacological (sibutramine and 
topiramate) and psychological (cognitive behavioral therapy - CBT) 
interventions.34-36 In general, our results were similar to those 
already reported in the literature, suggesting that BED is a global 
phenomenon also observed in Latin America.
BED has drawn increasing attention from clinicians and 
researchers, what is demonstrated by the fact that 26 out of the 
30 Latin American publications selected for this review consisted 
of empirical studies. The frequency with which the syndrome is 
manifested justifies the research on BED. Epidemiological studies 
report BED prevalence rates around 0.7% and 3% in the general 
population, which makes BED more frequent than classical AN and 
BN.37,38 Although no Latin American epidemiological studies in the 
general population were found, our results point to the prevalence of 
BED in clinical populations of obese individuals seeking treatment 
as ranging between 16% and 51.6%, equivalent to the frequencies 
between 7.5% and 30% reported by international services39,40 
and 11% and 49% among obese patients awaiting bariatric 
surgery.41,42 Some of our findings refer to the manifestation of BED 
in adolescence: in a non-clinical population of youth (12-18 years) 
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from Venezuela,14 the prevalence of BED was 0.66% (0.51% in 
girls and 0.14% in boys), and a Brazilian study23 reported that 
1.8% of a sample of young students (15-17 years) had BED. In 
countries outside Latin America, studies with samples of adolescents 
have shown similar rates. A Norwegian investigation involving 
participants aged 14-15 described a prevalence of 0.4% for each 
gender,43 and a North American study found BED rates of 1.9% 
among girls and 0.34% among boys with a mean age of 14 years.44
The identification of clinical and demographic aspects capable 
of distinguishing BED from other diagnostic categories of ED 
is crucial for its validation as a distinct category. It cannot be 
inferred from our data, however, that the incidence of BED is 
higher among adult obese women, as reported in most of the studies 
included in this review, since 10 of them included only female 
samples and 14 included only obese patients. Nonetheless, one of 
the articles reviewed17 that compared groups of women with BED 
and BN found that the former comprised older people. The findings 
that BED affects mainly older people and women (although the 
proportion across genders is similar: three women for every two 
men45) and that it is frequently connected with obesity support its 
differentiation from AN and BN, both conditions affecting mostly 
adolescent and young women and commonly associated with lower 
BMI over life.10,46,47 
Little has been done in the sense of evaluating the diagnostic 
validity of BED through instruments in Spanish or Portuguese. 
Two self-rating scales in Portuguese have been validated, and only 
one of them, the Questionnaire on Eating and Weight Patterns – 
Revised (QEWP-R7) assesses the diagnosis of BED according to the 
DSM-IV. The other instrument, the Binge Eating Scale (BES48) 
has been mainly designed to evaluate the severity of binge eating 
symptoms, and not to diagnose BED. The Portuguese versions 
of these instruments have adequate psychometric qualities, with 
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good positive predictive value and specificity in the case of the 
QEWP-R (79.3% chance to identify BED cases). The BES proved 
highly sensitive for the presence of binge eating symptoms, although 
diagnoses must be confirmed through clinical interview. Only one 
study from Argentina13 used the Spanish version of the Eating 
Disorders Examination (EDE - version 12),49 the gold standard 
for the diagnostic evaluation of ED. Therefore, the scarcity of valid 
and easily applied instruments for Latin American populations is 
an obstacle to further investigations in this field in Latin America.
One study assessed the presence of DSM-IV criteria for the 
diagnosis of BED: B (presence of behavioral indicators associated 
with loss of control during BEE), C (presence of distress), and 
D (frequency of BEE).14 This is an interesting study because it 
investigated the frequency with which these criteria were fulfilled 
by people with symptoms suggestive of BED, contributing for the 
characterization of symptoms that are relevant for the diagnosis. 
The study found that 100% of patients with a partial diagnosis of 
BED fulfilled a subthreshold criterion related to the frequency of 
BEE in BED: two episodes in one week over three months. Wilson 
and Sisko suggest that the duration of three months be maintained 
for both the diagnosis of BN (as it is already in the DSM) and 
BED (currently requiring a period of six months in the DSM) in 
the new edition of the DSM.50 The ICD-10 describes no specific 
duration of symptoms for ED diagnoses. Quintero-Párraga et al.14 
reported a frequency of 33-55% for the occurrence of behavioral 
indicators of loss of control (see Table 2) related to BEE (described 
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in criterion B).2 This is a relevant finding because few studies refer 
to the frequency and importance of such indicators for the diagnosis 
of BED. Some authors state that existing evidence concerning these 
indicators provide moderate support for the diagnosis of BED,12 
although further studies are necessary to validate BED indicators.
In respect to clinical features, obese female patients with BED 
had higher weight, greater weight oscillation, and greater concern 
about body weight and shape (or body image) as compared to 
obese women without BED.17,24 Similar data have been described 
in the literature, where dissatisfaction with weight, past and 
current presence of excessive body weight, and weight fluctuations 
distinguished between obese subjects with BED and obese 
individuals without the syndrome.51-53
Three studies comparing samples with and without BED22,26,54 
and one comparing full and partial BED, BN, and healthy 
volunteers17 showed an important association between BED and 
psychiatric comorbidities, especially mood and anxiety disorders. 
Additional findings concerning comorbidity describe the association 
of BED with other psychopathological conditions or symptoms, such 
as attention deficit hyperactivity disorder,55 alexithymia, impulsivity 
(e.g., self-harm), somatization, psychoticism, and others.15,17,22,24,25 
Our findings corroborate the observations of two recent literature 
reviews10,11 summarizing research results on BED that showed a 
higher frequency of associated psychiatric conditions in obese BED 
patients compared to obese individuals without BED. According to 
Wonderlich et al., the presence of psychiatric comorbidity in BED is 
not related to the presence of obesity in itself, since it is also observed 
in non-obese BED patients, but it is associated with the occurrence 
of BEE.10 Likewise, Latner and Clyne state that the harm caused by 
BED seems to be independent of the presence of obesity.12 Therefore, 
patients with BED, regardless of being obese, evolve differently 
from healthy individuals, that is, with more associated psychiatric 
symptoms and potential quality of life impairment.56
Although the literature on BED has plenty of evidence supporting 
its distinction in relation to people without ED, and especially obese 
individuals without BED, few classificatory studies (involving 
taxometric and latent class analyses) including obese people with 
and without BED support this discrimination so far,10 and no such 
studies have been performed in Latin America.
There are also few studies published to date dealing with the 
atypical forms of AN and BN. Only one article included in this 
review compared a group that completed the required criteria for 
atypical BN in the ICD-10, but not for BED in the DSM-IV, and 
a group completing diagnostic criteria for both diagnoses.25 The 
two groups presented more severe symptoms of binge eating and 
major depressive episode as compared to a control group without 
ED. When these two groups were compared amongst themselves, 
the one with atypical BN had higher scores of psychiatric symptoms 
including somatization, obsessive-compulsive traits, and anxiety. 
This study contributed to the distinction between patients with 
ED (both atypical BN and BED) and obese controls without 
ED from the psychopathological viewpoint. However, the higher 
frequency of comorbid psychiatric conditions in the atypical BN 
group (potentially including subjects with partial BN) is suggestive 
of the differentiation between atypical BN and BED. The lack of 
accuracy of the ICD-10 diagnostic criteria does not allow for a clear 
distinction between partial BN (syndromes with characteristics 
that are closer to those of BN) and BED, which may favor the 
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inclusion of patients in the atypical BN category who actually have 
less severe psychiatric comorbidity and associated psychopathological 
symptoms, and that may thus have different clinical evolutions.25 
There are two different categories in the ICD-10 to diagnose partial 
and full presentations of BN (BN and atypical BN). Greater 
coherence is likely to be achieved if the BN category is expanded 
so as to include atypical BN and a distinct category is created to 
classify BED.
In respect to physical comorbidity, two studies indicated an 
association between BED and type 2 diabetes mellitus, with 
prevalence rates of 10%28 and 28.6%29 in clinical populations with 
diabetes. The second study highlighted the negative impact of BED 
on weight and the impairment of the metabolic control in diabetic 
patients. A North American study57 described an association of BED 
and type 2 diabetes mellitus of 25.6%, and a higher frequency 
of obesity, consonant with our findings. The identification of 
BED in populations with diabetes may help improve the clinical 
management and evolution of this condition.28,29
Randomized, placebo-controlled trials assessed pharmacological 
interventions (sibutramine)34 alone or in association with CBT 
(topiramate)36 to treat obese patients with BED. Both treatments 
were efficient, especially in respect to the decrease or remission of 
BEE and weight loss. A non-controlled clinical trial with CBT 
also reported positive effects on BED symptoms.35 Meta-analyses 
on the efficacy of treatments for BED showed a moderate effect of 
medications on BEE,58,59 as well as supported CBT as the technique 
of choice to treat BED,58,60 although expressive results in terms of 
weight loss are not commonly observed with psychotherapy.37 Our 
finding that BED responds to pharmacological and psychological 
interventions demonstrates the clinical usefulness of this diagnosis; 
however, limitations in the design of the studies reviewed hamper 
the examination of the specificity of these interventions for the 
treatment of BED in relation to other ED, since no study compared 
more than one intervention or diagnostic group.
A study with obese patients who underwent gastric bypass 
surgery identified a frequency of 20% of BED after six months of 
follow-up.61 Two years later, these patients had lost less weight than 
the group without BEE. The authors support, therefore, a worse 
prognosis for those with a history of binge eating after gastric bypass 
surgery and raise the hypothesis that the early identification of BED 
followed by adequate treatment would favor a better post-surgical 
evolution.61 Although these findings were confirmed by a North 
American study with 2-7 years of post-surgical follow-up,62 other 
investigations do not support the impact of BEE or BED in the 
post-surgical evolution of obese patients63,64 and therefore further 
investigation is warranted to clarify this prognostic aspect. The 
identification of BED or BEE in candidates for bariatric surgery 
and after operation, however, may contribute for the control of 
their potential implications.
The similarities between Latin American and international 
studies lend support to the consistency and specificity of the 
manifestation of BED. Nonetheless, the literature recognizes 
limitations to this diagnosis related to the criteria proposed in 
DSM,12 as well as to other factors concerning its construct validity, 
such as the paucity of investigations on etiological factors (e.g., 
neurobiological findings) and clinical course in representative 
population samples.10
The diagnostic differences that emerge with the application 
and comparison of ICD-10 and DSM-IV criteria are currently 
under discussion, as well as their implications for research and 
communication between clinicians. According to a survey by 
Nicholls and Arcellus that examined the number of studies 
published between 2005 and 2009 which used the ICD-10 or 
DSM-IV to classify patients with ED, only 4 (out of 236) used 
only the ICD-10.65 This finding demonstrates the limitations 
of the use of  ICD-10 for research in the field. Despite the large 
number of categories in the ICD-10, the authors stated that many 
of these categories are not easily differentiated and that the inter-
rater reliability for atypical presentations of ED is low. It has been 
recommended65,66 that atypical presentations be described in a more 
specific and consistent way so as to allow their diagnosis, although 
they do not support BED as a distinct category but as a presentation 
of the category “overeating associated with other psychological 
disturbances”. Although major changes in classification systems 
are not convenient due to their implications (related to existing 
diagnostic instruments and research findings), we consider that there 
is enough information to support the characterization of BED as a 
distinct entity and acknowledge that the diagnosis of BED is already 
in use by specialists in the field in clinical practice.
This review has limitations that deserve mention: some of the 
studies reviewed involved small samples; there are no epidemiological 
investigations in general Latin American populations, nor studies 
dealing with other strategies of validation (e.g., laboratory findings, 
genetics or family history); in general, the studies examined used a 
cross-sectional design; the screening instruments used were mostly 
self-rated; few studies provided comparative data between subjects 
with BED and other ED, restricting the differentiation of BED 
from other eating pathologies; and no studies used the ICD-10 
alone as classification system to identify patients with symptoms 
suggestive of BED.
Despite these limitations, studies involving Latin American 
populations suggest that the characteristics of the presentation 
Palavras MA et al.
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of BED in Latin America are similar to those reported in the 
international literature. BED is distinct from normality due to 
its clinical aspects, and its presence in obese patients allows the 
differentiation between affected and non-affected obese individuals, 
which supports the consideration of BED as a distinct eating 
disorder in the ICD-11.
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